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Introduction: Acute and mid-term effects of ablation for atrial ﬁbrillation (AF) on left atrial (LA) and left
ventricular (LV) function and the atrial electromechanical interval are controversial.
Methods: Echocardiographic variables and the PA-TDI interval (time from ECG lead II P-wave onset to
lateral a0 wave on tissue Doppler tracings, indicating the total atrial conduction time [TACT]) were
evaluated in 33 paroxysmal AF patients before, 1 day, and 3, 6, and 12 months after ablation.
Results: During a 12-month follow-up, 10 (30.3%) patients had recurrent AF, associated with a greater
baseline LA volume (LAV) (48.4719.3 mm3 vs. 38.7711.4 mm3, P¼0.0811) and PA-TDI interval
(163.9711.0 ms vs. 151.1714.6 ms, P¼0.0189) than in patients without AF recurrence. By 6 months
after ablation, LAV had decreased progressively in the non-recurrence group (27.978.1 mm3, Po0.0001
vs. baseline), but the decrease was modestly signiﬁcant in the recurrence group (36.377.5 cm3,
P¼0.0380). LV ejection fraction (LVEF) modestly increased 1 day after ablation in both groups and
remained unchanged in the non-recurrence group (67.978.1% at baseline to 70.575.9% at 12 months,
P¼0.1711), whereas it decreased gradually below the baseline value in the recurrence group (68.2711.3%
to 60.9713.6%, P¼0.1025). The PA-TDI interval did not change during follow-up in either group, but
remained longer in the recurrence group.
Conclusions: The PA-TDI interval may be useful for predicting post-ablation AF recurrences. The patterns
of time-course changes in LAV, LVEF, and TACT differ, but the effects of ablation were better in patients
without AF recurrence after ablation.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Over the past 10 years, pulmonary vein isolation (PVI) has been
used as an effective therapy for atrial ﬁbrillation (AF) [1]. Never-
theless, the progression of atrial electrical and structural remodel-
ing requires additional aggressive ablation strategies, i.e., a
complex fractionated atrial electrogram (CFAE) ablation and/or
atrial linear ablation. Despite such treatments, the post-ablation
AF recurrence rate is higher in patients treated aggressively for
atrial remodeling than in patients with less extensive remodeling
of the atria treated with PVI alone [2,3]. Determining the extent of
structural and electrical atrial remodeling before ablation is
relevant for selecting AF ablation strategies. Structural and elec-
trical atrial remodeling are estimated by the left atrial (LA) size,
volume (LAV), a shortened atrial refractory period, or a prolonged
total atrial conduction time (TACT) [3–7]. Recently, the time
interval in the electrocardiogram (ECG) lead II from onset of the
P wave to the lateral mitral annulus a0 velocity wave, as assessed
with tissue Doppler imaging (PA-TDI interval), has been shown to
represent the electromechanical interval reﬂecting the TACT [6,8–10].
Therefore, we investigated whether this echocardiographic variable
could be used to identify patients prone to AF recurrence following
catheter ablation.
There is increasing evidence that the maintenance of sinus
rhythm following AF ablation results in reversed structural and
electrical remodeling of the atria during follow-up [4,11–15].
This study aimed to elucidate the short- and long-term effects
of AF ablation on atrial and left ventricular function and the
atrial electromechanical interval as assessed with standard and
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tissue Doppler-based echocardiography. Additionally, we sought to
analyze the time course of the changes in these variables during
the short- and mid-term follow-up periods after AF ablation.
2. Methods
2.1. Study patients
The study group comprised of 33 consecutive patients with
paroxysmal AF (spontaneous termination within 7 days; 27 men,
6 women; mean age, 57.579.5 years) referred to Nihon University
Itabashi Hospital for a ﬁrst radiofrequency catheter ablation. This
study excluded patients with non-paroxysmal AF lasting 47 days,
and those undergoing repeat procedures. All patients provided
written informed consent for the electrophysiologic study and
ablation procedure. This study was approved by the medical ethics
committee of our institution (date of approval: Sep 9th, 2011,
approval no. RK-110909-2). Adequate oral anticoagulation was
administered for at least 1 month before the procedure. All
antiarrhythmic drugs were discontinued for at least 5 half-lives
prior to the ablation. Upon hospital admission, a medical history,
physical examination, 12-lead ECG, chest radiograph, and transe-
sophageal and transthoracic echocardiograms were obtained. All
patients underwent multi-slice computed tomography on a 320-
row detector, dynamic volume scanner (Aquilion ONE; Toshiba
Medical Systems, Tokyo, Japan) to obtain a 3-dimensional recon-
struction of the left atrium and pulmonary veins (PVs).
2.2. Electrophysiologic study and ablation procedure
The procedure was performed under intravenous sedation with
propofol and fentanyl as previously described [3]. In brief, after
vascular access was obtained, a single transseptal puncture was
performed and followed by extensive ipsilateral PVI, guided by
double Lasso catheters and by using a 3-dimensional geometric
map generated by a NavX (St. Jude Medical, St. Paul, Minnesota) or
CARTO (Biosense Webster, Inc., Diamond Bar, California) mapping
system [1–3]. A 3.5-mm irrigated-tip catheter (ThermoCool, Navistar,
Biosense Webster) was used for ablation. Radiofrequency energy
was delivered at a maximum power output of 30W, and the upper
temperature limit was set to 41 1C at a saline irrigation rate of
17 mL/min (CoolFlow Pump; Biosense Webster). The endpoint of
PVI was the elimination or dissociation of all PV potentials and the
Non-recurrence
Pre ablation PA TDI 146 ms 1 day post PA TDI 146 ms 12mo post PA TDI 142 ms-  = - -  = - -  = 
Recurrence
Pre ablation PA TDI 175 ms 1 day post PA TDI 182 ms 12mo post PA TDI 179 ms-  = - -  = - -  = 
Fig. 1. Examples of the measurement of the PA-TDI interval in patients without (A) and with (B) recurrence of atrial ﬁbrillation after ablation. Upper image shows an apical
4-chamber view and the lower images show tissue Doppler tracings. The PA-TDI is measured as the time interval from the onset of the P wave in ECG lead II to the peak
a´ wave of the left lateral atrial wall on the tissue Doppler tracing. The mean PA-TDI intervals in the patient with no AF recurrence are 146 ms before ablation, 146 ms on day
1 after ablation, and 142 ms at 12 months after ablation; in the patient with recurrence, the mean PA-TDI intervals are 175 ms before ablation, 182 ms on day 1 after ablation,
and 179 ms at 12 months after ablation.
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attainment of complete entrance and exit block. Linear ablations at
the left atrial roof and ﬂoor along the coronary sinus (CS) and/or
CFAE ablations based on the post-PVI CFAE map were performed in
patients in whom AF was not terminated by PVI or those in whom
sustained AF lasting more than 5 min was inducible by rapid atrial
pacing [2,3]. The endpoint of these steps was the termination of AF
during the procedure or the abolition of all CFAEs in the left atrium, if
AF was not terminated. Cavotricuspid isthmus ablation was also
performed when typical atrial ﬂutter could be induced with burst
atrial pacing or was observed clinically.
2.3. Echocardiographic evaluation
Transthoracic echocardiography was performed 1 day before
ablation and 1 day, 3 months, 6 months, and 12 months after
ablation, using an ACUSON Sequoia C256 echocardiography sys-
tem (Siemens Medical Solutions USA, Inc., Malvern, Pennsylvania).
Standardized measurements were obtained: maximum LAV was
measured with the prolate-ellipsoid method [16], and left ven-
tricular ejection fraction (LVEF) was assessed with M-mode echo-
cardiography (Teichholz's method). An apical 4-chamber view
using Doppler tissue imaging was used to image the mitral
annulus, and the following indices of LV diastolic and LA function
were measured: (1) the ratio of the mitral inﬂow early ﬁlling
velocity (E) to atrial ﬁlling velocity (A) (E/A ratio), (2) the ratio of E
to the velocity of the septal early mitral annular ascent (e0), (3) the
velocity of the a0 wave on the lateral LA tissue Doppler tracing
(lateral a0) and (4) the PA-TDI interval (Fig. 1). These variables were
measured in 3 consecutive beats and the results averaged. All
measurements were performed by two echocardiographers, each
with more than 5 years of experience.
2.4. Post-ablation follow-up
The patients' prescribed antiarrhythmic drugs were resumed
after the procedure but were stopped after a 2-month post-
ablation blanking period. All patients underwent routine follow-
up at our outpatient clinic, where a clinical evaluation and 12-lead
electrocardiography were performed at 2 weeks and at 1, 3, 6, and
12 months after ablation. We also obtained 24-h Holter recordings
at 3, 6, and 12 months after ablation. ECG event monitoring was
used whenever the patient reported any cardiac symptoms.
Successful ablation was deﬁned as non-recurrence of an AF
episode lasting more than 30 s as assessed with a standard ECG,
ECG event monitor, or 24-h Holter recording during the 12-month
follow-up period after the 2-month post-ablation blanking period.
We compared the procedural outcome, baseline characteristics,
and transthoracic echocardiography measurements between the
patients who had episodes of AF recurrence (AF recurrence group)
and non-recurrence (non-recurrence group).
2.5. Statistical analysis
Continuous variables are expressed as mean7SD or median
and interquartile range. Between-group differences were analyzed
by using Student's t-test or the Mann–Whitney U test as appro-
priate. Categorical variables are expressed as percentages, and
differences were analyzed with a chi-square test. A paired t test
was used to analyze within-group differences in the variables
measured at different time points. A P value of o0.05 was
considered statistically signiﬁcant. Statistical analyses were per-
formed with JMP 9 software (SAS Institute, Cary, NC).
3. Results
3.1. Procedural outcome, baseline characteristics, and transthoracic
echocardiography measurements in the AF recurrence group and
non-recurrence group
In 19 (58%) of the 33 patients, sustained AF could not be
induced after PVI. Six (18%) patients required additional LA linear
Table 1
Baseline characteristics, Ablation results, and echocardiographic parameters in patients without and with AF recurrence.
No recurrence
(n¼23)
Recurrence
(n¼10)
P valuen
Age, years 57.679.9 57.179.0 0.8907
Sex: male 20 (87.0) 7 (70.0) 0.2458
AF duration, months 48 (24–73) 57 (16–88) 0.9219
Body mass index, kg/m2 22.872.9 24.773.3 0.1152
Casual factors
Hypertension 8 (34.8) 3 (30.0) 0.7888
Diabetes mellitus 1 (4.4) 2 (20.0) 0.1506
Ischemic heart disease 2 (8.7) 0 (0) 0.3360
Heart failure 0 (0) 1 (10.0) 0.1235
Ablation result
Terminated by PVI 16 (69.6) 3 (30.0) 0.0346
Terminated by PVIþLA substrate-based ablation 4 (57.1) 2 (28.6) 0.2801
TTE variable
LAV (cm3) 38.7711.4 48.4719.3 0.0811
LVDd (mm) 48.573.9 52.276.5 0.0506
LVDs (mm) 30.073.9 32.378.4 0.2892
LVEF (%) 67.9768.2 68.2711.3 0.9493
E/A 1.370.5 1.070.3 0.1099
DcT (cm/s) 179.5731.9 179.4733.4 0.9921
E/e0 6.572.0 6.671.8 0.9605
Lateral a0 (cm/s) 11.474.2 13.674.9 0.1909
PA-TDI interval (ms) 151.1714.6 163.9711.0 0.0189
AF, atrial ﬁbrillation; DcT, deceleration time; LA, left atrium; LAV, LA volume; LVDd, left ventricular diastolic diameter; LVDs, LV systolic diameter; LVEF, LV ejection fraction;
PA-TDI, time interval from onset of the P wave in ECG lead II to the peak a0 wave of the left lateral atrial wall; PVI, pulmonary vein isolation; TTE, transthoracic
echocardiography.
Values are the mean7SD, median (interquartile ranges), or n (%).
n No recurrence vs. recurrence.
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ablation and/or CFAE-based ablation to terminate the AF. In the
remaining 8 (24%) patients, AF was not terminated despite
performance of these ablation steps. During a follow-up period
of 12 months, 10 (30.3%) of the 33 patients had AF recurrence. The
clinical and echocardiographic characteristics of the AF recurrence
group and the non-recurrence group are listed in Table 1. There
were no statistically signiﬁcant differences in the baseline char-
acteristics. As expected, AF that was terminated by PVI was
more common in the non-recurrence group than in the
recurrence group.
At baseline, LAV and LV diastolic diameter tended to be larger
in the AF recurrence group than in the non-recurrence group. The
PA-TDI interval was signiﬁcantly longer in the AF recurrence
group than in the non-recurrence group (163.9711.0 ms vs.
151.1714.6 ms, P¼0.0189).
3.2. Echocardiographic evaluation during follow-up
Echocardiographic measurements were evaluated in all 33
patients at 3 months (2.870.6 months), 6 months (6.370.8
months), and 12 months (12.071.1 months) after ablation.
3.2.1. Changes in LA volume and function
The changes in each of the echocardiographic variables are
shown in Table 2. LAV decreased progressively during the 6 months
after ablation in the non-recurrence group (Po0.0001, baseline
vs. 6 months) whereas the decrease was modestly signiﬁcant in
the recurrence group (P¼0.0380). LAV increased thereafter
and returned to approximately baseline levels at 12 months in
both groups (Fig. 2A). During the follow-up period, there was no
signiﬁcant improvement in the lateral a0 in either the non-
recurrence group or the recurrence group.
3.2.2. Changes in LV systolic and diastolic function
In the non-recurrence group, LV diastolic and systolic diameters
decreased progressively by 12 months after ablation (P¼0.0187
and P¼0.0472, respectively for the values between the baseline vs.
12 months), whereas the decreases were non-signiﬁcant in the
recurrence group (P¼0.0892 and P¼0.8693, respectively). In the
non-recurrence group, LVEF tended to be increased on day 1 after
ablation (P¼0.0905 vs. baseline value), but thereafter, no further
improvement was observed during the follow-up period. In the
recurrence group, LVEF tended to be increased 1 day after ablation
(P¼0.0783), but it decreased gradually below the baseline value
by 12 months after ablation (Fig. 2B). The E/e0 and E/A ratio
measured during the follow-up period did not change signiﬁcantly
from the baseline values in either group (Fig. 2C).
3.3. Impact of the ablation outcome, extensive LA-based ablation
strategy, and use of anti-arrhythmic drugs on the PA-TDI interval
There was no change between the baseline and 12-month post-
ablation PA-TDI interval in either the non-recurrence group or AF
recurrence group (Fig. 2D). To clarify the effect of the extensive
Table 2
Follow-up transthoracic echocardiographic parameters in patients without and with AF recurrence.
Before ablation 1 day 3 months 6 months 12 months
HR (beats/min)
No rec 60.879.3 75.375.9n 64.379.2 62.878.6 64.279.2
Rec 56.675.4 77.5715.6n 66.5711.6n 72.2716.7n 64.9712.1n
LAV (cm3)
No rec 38.7711.3 40.7714.3 30.279.8n 27.978.1n 41.478.0
Rec 48.4719.3 52.2717.5 39.6711.2 36.377.5n 49.3716.4
LVDd (mm)
No rec 48.573.9 47.973.6 46.874.6n 46.776.5 47.073.1n
Rec 52.276.5 49.277.8n 48.975.2n 48.975.5n 50.476.3
LVDs (mm)
No rec 30.073.9 28.374.0n 29.073.7 28.174.5n 28.172.7n
Rec 32.378.4 29.178.1n 30.975.6 30.476.0 32.777.8
LVEF (%)
No rec 67.978.1 71.476.3 68.274.8 69.877.3 70.575.9
Rec 68.2711.3 71.779.4 66.578.6 66.779.4 60.9713.6
E/A
No rec 1.370.5 1.370.4 1.170.3 1.270.4 1.270.3
Rec 1.070.3 1.270.4 1.170.4 1.070.2 1.270.5
DcT (ms)
No rec 179.5731.9 174.3729.0 202.9745.1n 188.8760.0 200.2740.9n
Rec 179.4733.4 185.6749.7 214.3745.2n 215.5748.2n 210.9765.1
E/e0
No rec 6.572.0 7.272.3 6.272.5 6.872.5 6.672.4
Rec 6.671.8 7.972.5 7.273.0 6.872.3 7.172.0
Lateral a0 (ms)
No rec 11.474.2 13.675.4 12.272.9 11.873.0 12.773.3
Rec 13.674.9 12.874.3 10.972.0 12.574.9 10.373.4
PA-TDI (ms)
No rec 151.0714.6 148.9720.3 148.8722.7 146.8713.7 149.7719.1
Rec 163.9711.0 159.7718.4 166.0719.9 161.0720.9 156.9719.3
AF, atrial ﬁbrillation; HR, heart rate; No rec, no recurrence of atrial ﬁbrillation (n¼23); rec, recurrence of atrial ﬁbrillation (n¼10); LA, left atrial volume; LVDd, left ventricular
diastolic diameter; LVDs, LV systolic diameter; LVEF, LV ejection fraction; PA-TDI, time interval from onset of the P wave in ECG lead II to the peak a0 wave of the left lateral
atrial wall; PA-TDI, time interval from onset of the P wave in ECG lead II to the peak a0 wave of the left lateral atrial wall. Values are the mean7SD.
n Po0.05 vs. value before ablation.
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LA-based ablation strategy on the PA-TDI interval, we compared
the PA-TDI interval between baseline and day 1 after ablation in
the patients who underwent PVI plus LA substrate-based ablation
(n¼14). The baseline PA-TDI interval was not prolonged at 1 day
after PVI plus LA substrate-based ablation (159.8713.7 mm at
baseline and 153.2721.3 mm after day 1, P¼0.1490).
To exclude the effect of the use of class I anti-arrhythmic drugs,
we assessed the PA-TDI interval in 22 (60.0% of the study patients)
patients who were not prescribed class I antiarrhythmic drugs
during follow-up. In this subgroup, there were no changes in the
PA-TDI interval between baseline and 6 months (154.6716.4 ms
vs. 149.9718.2 ms, P¼0.2001) or 12 months after ablation
(151.7720.5 ms, P¼0.4963 vs. baseline value).
4. Discussion
The present study showed changes in speciﬁc echocardio-
graphic variables during the 1-year follow-up period after AF
ablation. The main ﬁndings were that (1) LAV was larger and PA-
TDI interval was longer in patients with AF recurrence than in
those without, (2) reverse LAV and LV diameter remodeling was
noted, especially in patients with no AF recurrence, but there was
no change in the PA-TDI interval, lateral a0, or LV systolic and
diastolic function over 1 year regardless of any AF recurrence, and
(3) there were no changes in the PA-TDI interval before and after
ablation in patients with the extensive ablation strategy, even in
those not using anti-arrhythmic drugs.
4.1. Relationship between baseline characteristics, general
echocardiographic variables, and PA-TDI interval and AF recurrence
post-ablation
In our patient series, AF recurrence was related to a relatively
increased LAV and LV diastolic diameter. These variables have been
shown to be hallmarks of progressive LA remodeling, as well as
strong predictors of the recurrence of AF post-ablation [3–7]. Our
patients who experienced AF recurrence also had a longer PA-TDI
interval than patients without recurrence. Recently, the PA-TDI
interval has been reported to correlate well with the signal-
averaged P-wave duration [8], and that these variables can be
used as non-invasively obtained predictors of TACT [6,8–10]. An
increase in the TACT, which reﬂects the intra-atrial conduction
time, can include slowing of atrial conduction and increased atrial
dilatation, leading to a progression of LA remodeling [4,17,18]. LV
diastolic dysfunction, valve incompetence, and an enlarged atrium,
determined through echocardiography, are associated with a
prolonged PA-TDI interval [19]. Therefore, a prolonged PA-TDI
interval may be a surrogate marker for the existence of a substrate
vulnerable to AF.
4.2. Changes in echocardiographic variables after AF ablation
We found that reverse remodeling of the LAV and LV diameters
was observed by 6 months after ablation, especially in the non-
recurrence group. These ﬁndings are consistent with previous
reports that AF patients, in whom sinus rhythm was maintained
after catheter ablation or cardioversion, had a signiﬁcant reduction
in LA size during the mid- and long-term follow-up periods [12–15].
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Fig. 2. Graphs showing transthoracic echocardiographic measurements in the patients without (●) and with AF recurrence (■) before and at 1 day, and 3, 6, and 12 months
after the ablation. LAV, left atrial volume; LVEF, left ventricular ejection fraction; mo, months; PA-TDI, time interval from the onset of the P wave in ECG lead II to the peak
a0 wave of the left lateral atrial wall. nPo0.05 vs. value before ablation. (a) LAV, (b) LVEF, (c) E/e0, and (d) PA-TDI.
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Interestingly, we found that LAV and LV diameter returned to or
below the baseline values at 12 months after ablation, despite the
maintenance of sinus rhythm. Our ﬁndings suggest that reverse
remodeling is a relatively short-term phenomenon that does not
persist; i.e., some patients with non-recurrence of AF and a modest
increase in LA dimension might experience a late AF recurrence.
Although there is strong evidence that reverse remodeling in terms of
LAV and LV systolic function occurs in the mid- to long-term follow-
up period after ablation, whether reverse remodeling occurs in terms
of LV diastolic function is controversial [12–15]. In the present study,
the E/e0 and E/A ratio did not change over 1 year in either the
recurrence or non-recurrence group. Most recent studies have found
no change or an increase in the E/e0 ratio, despite improvement in the
LA strain function, during the mid- to long-term follow-up period
[12–14]. An earlier study highlighted the important contribution of AF
suppression by RF ablation, especially for improving LV diastolic and
systolic function [15]. The substantially higher baseline E/e0 reported
in that study might have allowed for a greater improvement than that
seen in the present and other recently reported studies.
LVEF measured on day 1 after ablation did not change in either
group. Over 1 year, it remained above the baseline level in the
non-recurrence group, whereas it eventually decreased below the
baseline level in the recurrence group. The small increase in LVEF
at day 1 after ablation might be due to the change in the
hemodynamic status that occurs after invasive ablation. However,
the small increase remained for up to 6 months after ablation,
indicating a link to the progressive reduction in LAV that occurred,
especially in the non-recurrence group. This suggests that an
improvement in LV systolic function by 6 months may be caused
by the improvement in LA function.
4.3. Changes in the PA-TDI interval after AF ablation
Surprisingly, we found no change in the PA-TDI intervals during
the follow-up period regardless of whether AF recurred. A majority
of recent studies have shown that a signiﬁcant decrease in the
P-wave duration, signal-averaged P-wave duration, or TACT,
measured on 3-dimensional maps, occurs in the acute phase and
remains during the short-to-mid-term period after AF ablation
[11,20–22]. These studies suggested that the shortening of the
TACT that occurs after ablation might be caused by a conduction
block in the PVs [11,20,21], reverse electrical remodeling [11], or a
change in the breakthrough site in the LA, after the PV is isolated
from the site of Bachmann's bundle to the medial septum [22]. The
cause of an unchanged PA-TDI interval after AF ablation that we
observed in our patient series remains unclear. One possibility is
that LA substrate-based ablation might prolong the PA-TDI inter-
val, which is overcome and thus masks the shortening of the TACT
that results from a conduction block within the PVs or from
reverse electrical remodeling. However, this speculated mechan-
ism may not be the major cause; the baseline PA-TDI interval was
not prolonged on day 1 after ablation in the patients who under-
went PVI plus LA substrate-based ablation. The second possibility
is that it was due to the effects of antiarrhythmic drugs used after
ablation. Despite excluding data from patients using class I anti-
arrhythmic drugs, the PA-TDI interval did not change over 1 year.
Thus, this effect appears to be minor. Rather, the phenomenon
might occur from the different methodologies used to determine
the PA-TDI interval compared with those used to determine
P-wave duration or signal-averaged P-wave duration. The PA-TDI
interval may overestimate the overall atrial activation time,
resulting in no apparent effect by PVI, because the PA-TDI interval
includes both the time required for the propagation of impulses
from the sinus node area to the LA and the time required for the
electromechanical coupling in the LA. For example, the offset of
the PA-TDI was measured from the wall motion of the lateral LA
very close to the mitral annulus; therefore, it may have been
affected more signiﬁcantly by the wall motion of mitral annulus in
the LV end-diastolic phase rather than the exact wall motion of the
lateral LA. This speculation might provide an answer as to why the
PA-TDI interval was not affected by the ablation outcome, ablation
strategy, or use of antiarrhythmic drugs.
4.4. Limitations
The present study had several limitations. First, the study
included a small number of patients. Therefore, the number of
patients was inadequate for application of a multivariate analysis
to identify independent predictors of post-ablation AF recurrence.
Second, we limited the echocardiographic measurements to con-
ventional variables. An evaluation of LA strain or strain rate might
provide more information, especially in regard to LA reverse
remodeling [4,5,12–15]. However, we focused on LA reverse
remodeling as evaluated with standard echocardiographic vari-
ables and the PA-TDI interval to increase applicability to clinical
practice and to detailed time-based changes in these variables.
Third, the correlation between the PA-TDI interval and TACT
remains unclear because the TACT, determined by 3-dimensional
geometric maps or (signal averaging) P wave duration, was not
evaluated simultaneously with the PA-TDI. Finally, the incidence of
AF was derived partly from symptom-driven ECGs and 24-h Holter
recordings, which may have led to an underestimation of AF
recurrence, because a large number of AF episodes are known to
be asymptomatic.
5. Conclusions
In patients undergoing AF ablation, the PA-TDI interval might
be a predictor of AF recurrence after ablation. Changes over time
were observed in LAV and LV systolic and diastolic function, and
these variables improved in patients without AF recurrence, but
not in those with AF recurrence. Despite LA reverse remodeling,
the PA-TDI interval was unchanged after more than 1 year of
follow-up, regardless of the presence or absence of AF recurrence,
possibly indicating that the wall motion of the lateral LA remains
unchanged even after AF ablation.
Author contributions
Study concept/design: Yasuo Okumura.
Data analysis/interpretation: Hiroaki Mano, Yasuo Okumura.
Drafting the paper: Hiroaki Mano, Yasuo Okumura.
Critical revision of the paper: Hiroaki Mano, Yasuo Okumura,
Ichro Watanabe.
Approval of the paper: Hiroaki Mano, Yasuo Okumura, Ichiro
Watanabe, Masakatsu Ohta, Rikitake Kogawa, Naoko Sasaki,
Toshiko Nakai, Kimie Ohkubo, Masayoshi Kofune, Koichi Nagashima,
Kazumasa Sonoda, Hironori Haruta, Atsushi Hirayama.
Statistics: Hiroaki Mano, Yasuo Okumura.
Data collection; Masakatsu Ohta, Rikitake Kogawa, Naoko
Sasaki, Toshiko Nakai, Kimie Ohkubo, Masayoshi Kofune, Koichi
Nagashima, Kazumasa Sonoda, Hironori Haruta.
Disclosures and funding sources
None.
H. Mano et al. / Journal of Arrhythmia 30 (2014) 466–472 471
Conﬂicts of interest
None.
References
[1] Ouyang F, Bänsch D, Ernst S, et al. Complete isolation of left atrium
surrounding the pulmonary veins: new insights from the double-Lasso
technique in paroxysmal atrial ﬁbrillation. Circulation 2004;110:2090–6.
[2] Lin YJ, Tai CT, Kao T, et al. Spatiotemporal organization of the left atrial
substrate after circumferential pulmonary vein isolation of atrial ﬁbrillation.
Circ Arrhythm Electrophysiol 2009;2:233–41.
[3] Okumura Y, Watanabe I, Nakai T, et al. Impact of biomarkers of inﬂammation
and extracellular matrix turnover on the outcome of atrial ﬁbrillation ablation:
importance of matrix metalloproteinase-2 as a predictor of atrial ﬁbrillation
recurrence. J Cardiovasc Electrophysiol 2011;22:987–93.
[4] Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantiﬁcation of left
atrial structural remodeling with delayed-enhancement magnetic resonance
imaging in patients with atrial ﬁbrillation. Circulation 2009;119:1758–67.
[5] Tops LF, Delgado V, Bertini M, et al. Left atrial strain predicts reverse
remodeling after catheter ablation for atrial ﬁbrillation. J Am Coll Cardiol
2011;57:324–31.
[6] den Uijl DW, Gawrysiak M, Tops LF, et al. Prognostic value of total atrial
conduction time estimated with tissue Doppler imaging to predict the
recurrence of atrial ﬁbrillation after radiofrequency catheter ablation. Euro-
pace 2011;13:1533–40.
[7] Zhuang J, Wang Y, Tang K, et al. Association between left atrial size and atrial
ﬁbrillation recurrence after single circumferential pulmonary vein isolation: a
systematic review and meta-analysis of observational studies. Europace
2012;14:638–45.
[8] Merckx KL, De Vos CB, Palmans A, et al. Atrial activation time determined by
transthoracic Doppler tissue imaging can be used as an estimate of the total
duration of atrial electrical activation. J Am Soc Echocardiogr 2005;18:940–4.
[9] Chao TF, Sung SH, Wang KL, et al. Associations between the atrial electro-
mechanical interval, atrial remodeling and outcome of catheter ablation in
paroxysmal atrial ﬁbrillation. Heart 2011;97:225–30.
[10] De Vos CB, Weijs B, Crijns HJ, et al. Atrial tissue Doppler imaging for prediction
of new-onset atrial ﬁbrillation. Heart 2009;95:835–40.
[11] Okumura Y, Watanabe I, Ohkubo K, et al. Prediction of the efﬁcacy of
pulmonary vein isolation for the treatment of atrial ﬁbrillation by the
signal-averaged P-wave duration. Pacing Clin Electrophysiol 2007;30:304–13.
[12] Kuppahally SS, Akoum N, Badger TJ, et al. Echocardiographic left atrial reverse
remodeling after catheter ablation of atrial ﬁbrillation is predicted by
preablation delayed enhancement of left atrium by magnetic resonance
imaging. Am Heart J 2010;160:877–84.
[13] Donal E, Ollivier R, Veillard D, et al. Left atrial function assessed by trans-
thoracic echocardiography in patients treated by ablation for a lone parox-
ysmal atrial ﬁbrillation. Eur J Echocardiogr 2010;11:845–52.
[14] Ollivier R, Donal E, Veillard D, et al. Early and late cardiac ventricular reverse
remodeling after catheter ablation for lone paroxysmal atrial ﬁbrillation. Ann
Cardiol Angeiol (Paris) 2011;60:1–8.
[15] Reant P, Laﬁtte S, Jaïs P, et al. Reverse remodeling of the left cardiac chambers
after catheter ablation after 1 year in a series of patients with isolated atrial
ﬁbrillation. Circulation 2005;112:2896–903.
[16] Ujino K, Barnes ME, Cha SS, et al. Two-dimensional echocardiographic
methods for assessment of left atrial volume. Am J Cardiol 2006;98:1185–8.
[17] Spach MS, Boineau JP. Microﬁbrosis produces electrical load variations due to
loss of side-to-side cell connections: a major mechanism of structural heart
disease arrhythmias. Pacing Clin Electrophysiol 1997;20:397–413.
[18] Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial ﬁbrillation in
human patients. Cardiovasc Res 2002;54:361–79.
[19] Weijs B, de Vos CB, Tieleman RG, et al. Clinical and echocardiographic
correlates of intra-atrial conduction delay. Europace 2011;13:1681–7.
[20] Ogawa M, Kumagai K, Vakulenko M, Yasuda T, et al. Reduction of P-wave
duration and successful pulmonary vein isolation in patients with atrial
ﬁbrillation. J Cardiovasc Electrophysiol 2007;18:931–8.
[21] Udyavar AR, Huang SH, Chang SL, et al. Acute effect of circumferential
pulmonary vein isolation on left atrial substrate. J Cardiovasc Electrophysiol
2009;20:715–22.
[22] Van Beeumen K, Houben R, Tavernier R, et al. Changes in P-wave area and
P-wave duration after circumferential pulmonary vein isolation. Europace
2010;12:798–804.
H. Mano et al. / Journal of Arrhythmia 30 (2014) 466–472472
